The Topical Oxygen Wound Therapy segmentation by application distinguishes three principal clinical uses: chronic wounds, acute wounds, and burn injuries. Chronic wounds—including diabetic foot ulcers, pressure ulcers, and venous leg ulcers—represent the largest share, driven by the high prevalence of diabetes and an aging population; they account for roughly 55% of market revenue. Acute wounds, such as post‑surgical incisions and traumatic lacerations, contribute about 35% as they require rapid oxygenation to accelerate healing and reduce infection risk. Burn injuries, though a smaller niche, occupy the remaining 10% and are characterized by intensive oxygen demand for tissue regeneration. Each application segment influences overall market size by dictating device specifications, treatment protocols, and reimbursement pathways, thereby shaping investment priorities and R&D focus across the Topical Oxygen Wound Therapy market.